<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04259398</url>
  </required_header>
  <id_info>
    <org_study_id>Ane-Can colon (1912-133-109)</org_study_id>
    <nct_id>NCT04259398</nct_id>
  </id_info>
  <brief_title>Anesthesia and Cancer Study: Colon</brief_title>
  <official_title>The Influence of Type of Anesthesia on Mortality and Cancer Recurrence After Colon Cancer Surgery: Multi-center Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korean Society of Anesthesiologists</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bundang Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul St. Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Boramae Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the influence of type of anesthesia on survival and recurrence rate
      in patients receiving colon cancer surgery. The participants will be allocated to either the
      TIVA group and the inhalation group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of anesthesia on cancer recurrence and survival is controversial. According to
      some retrospective studies and preclinical studies, total intravenous anesthesia (TIVA) is
      suggested to be more favorable than inhalation anesthesia regarding cancer recurrence and
      survival after surgery. However, there is no randomized controlled study to determine this
      difference in colon cancer patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 18, 2020</start_date>
  <completion_date type="Anticipated">February 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>five year survival</measure>
    <time_frame>five years survival</time_frame>
    <description>survival rate regardless of recurrence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>five year recurrence free survival</measure>
    <time_frame>five years after surgery</time_frame>
    <description>survival rate without recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year recurrence free survival</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>survival rate without recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3 year recurrence free survival</measure>
    <time_frame>3 years after surgery</time_frame>
    <description>survival rate without recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year survival</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>survival regardless of recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3 year survival</measure>
    <time_frame>3 years after surgery</time_frame>
    <description>survival regardless of recurrence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">792</enrollment>
  <condition>Cancer of Colon</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>TIVA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>propofol infusion targeting bispectral index 40-60</description>
  </arm_group>
  <arm_group>
    <arm_group_label>inhalation (Sevoflurane)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sevoflurane targeting bispectral index 40-60</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>propofol 1-2 mg/kg bolus injection for induction of anesthesia propofol continuous infusion for maintenance of anesthesia</description>
    <arm_group_label>TIVA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>sevoflurane is administered for induction and maintenance of anesthesia</description>
    <arm_group_label>inhalation (Sevoflurane)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults undergoing surgery to remove colon cancer

        Exclusion Criteria:

          -  pregnancy

          -  colon cancer with invasion to perineum

          -  palliative surgery

          -  history of diagnosis or surgery for other cancer

          -  emergent surgery

          -  ASA PS classification 4 and 5

          -  refusion to participate in the study

          -  allergy to anesthetics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin-Tae Kim</last_name>
    <phone>+821062608490</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul Metropolitan Government Seoul National University Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>07061</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae Kyung Kim, Pf.</last_name>
      <phone>82-2-870-3020</phone>
      <email>ktkktk@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Tae Kim, Pf.</last_name>
      <phone>+82-2-2072-3295</phone>
      <email>jintae73@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2020</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor (full)</investigator_title>
  </responsible_party>
  <keyword>anesthesia</keyword>
  <keyword>propofol</keyword>
  <keyword>cancer</keyword>
  <keyword>inhalational anesthetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

